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The Effects of Perceived Stress and Attitudes Toward
Menopause and Aging on Symptoms of Menopause
Marcianna Nosek, CNM, MPH, PhD, Holly Kennedy, CNM, PhD, FACNM, FAAN, Yewoubdar
Beyene, PhD, Diana Taylor, RN, PhD, FAAN, Catherine Gilliss, RN, DNSc, FAAN, and
Kathryn Lee, RN, PhD, FAAN
School of Nursing at University of California San Francisco
Abstract
As part of a longitudinal study of midlife women, the aim of this investigation was to describe the
intensity of menopausal symptoms in relation to level of perceived stress in a woman’s life and
her attitudes toward menopause and aging. Data were collected on 347 women between the ages
of 40–50 in Northern California who began the study while pre-menopausal. Women self
identified as African American, European American, or Mexican/Central American. Data
collected over 3 time points in the first 12 months were used for this analysis. An investigator-
developed tool for perception of specific types of stress was used. Attitudes toward menopause
and aging were measured using the Attitudes Toward Menopause and Attitude Toward Aging
Checklists. Attitudes toward aging and menopause, perceived stress, and income were related to
intensity of symptoms. There was no ethnic group difference in perceived stress or attitude toward
menopause. However, European and African Americans had a more positive attitude toward aging
than Mexican/Central Americans. A lower income, higher perceived stress, a more negative
attitude toward aging, and a more positive attitude toward menopause influenced menopausal
symptom experience.
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INTRODUCTION
Currently in the United States there are more than 44 million women between 45–54 years
of age. More than half of women in this age group report physiological or psychological
symptoms often attributed to menopause, with 30% who indicate that symptoms are
bothersome. 2, 3 Frequently reported symptoms include difficulty sleeping, night sweats,
headaches, hot flushes or flashes, vaginal dryness, forgetfulness, dizzy spells, stiff joints,
feeling tense or nervous, feeling blue or depressed, and irritability.2 The inability to cope
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with these symptoms, particularly hot flashes, is the most frequent reason women of this age
group visit their healthcare provider.4
Menopause has been defined as the permanent cessation of menstruation due to loss of
ovarian follicular activity clinically presenting as 12 months of amenorrhea. Perimenopause
is a common, yet more vague term, historically used to herald the transition from when
menstrual and endocrine changes begin to occur until 12 months after the final menstrual
period.5 ‘Premenopause’ is another term that has traditionally denoted an arbitrary time
normally associated with the decade before typical menstrual changes are noted. 5 Studies
have shown that women may experience hormonal changes earlier than previously thought.5
Experts currently recommend using staging criteria for pre-, peri-, and post-menopause
based on empirical research findings. 5–7, Nomenclature has been proposed that includes
cycle length changes that begin to occur before episodes of amenorrhea.5–7 (Figure 1.)
Women who note a change in cycle length of more than seven days, but unaccompanied by
amenorrhea or an increase in follicle stimulating hormone (FSH) are in ‘early transition’ to
menopause. Those who report 90 days or more of amenorrhea accompanied by an increased
FSH enter ‘late transition’ to menopause.5–7 Cycle length changes contribute to the current
understanding of reproductive aging and may explain why women report symptoms earlier
than would be expected based on amenorrhea or FSH levels alone. 5–7
The presence and severity of symptoms vary tremendously from woman to woman and can
last from months to years during this transitional period. 2,4,–7 Some symptoms have been
attributed to a decline in estrogen, which accompanies menopause, but researchers do not
find consistent associations between hormone levels and symptom experience.2,3,5, 8, 9
The wide variation in symptom reporting motivated researchers to explore psychological or
social correlates of the menopausal symptom experience. Some have postulated that it is the
woman’s attitude toward menopause or aging, or issues related to self esteem and body
awareness that affect her ability to cope with the menopause transition.8, 10, 11 Others posit
that education, ethnicity, and lifestyle habits, including smoking, exercise and obesity, play a
role in the symptom experience. 2,12–15 Depression has also been reported to be associated
with menopause transition. 3,11, 16,17
Lazarus suggests that appraisals of challenging everyday life situations, whether conscious
or unconscious, are followed by a response, or emotion.18 The perception and meaning that
we place on these thoughts and actions may influence our appraisal of whether or not we
perceive the occurrence as a threat to our well-being. If a threat is perceived, a stress
response may be triggered which could subsequently have an effect on symptom experience.
Lazarus further proposed that emotions interconnect with social and physical conditions of
importance, personal values, and belief systems.18 Menopause and aging may be viewed as
a loss, or as a threat to youth. A woman’s attitude toward this change in her life may
subsequently influence her appraisal of the occurrence and may impact her level of distress
associated with the experience. A woman’s perception of symptoms alerts her to changes in
her body, and may propel her to explore ways to alleviate or manage the associated distress.
Dodd and colleagues have conceptualized symptom experience as an interface between
perception and evaluation that can be positive and result in a healthy healing response, or
can be problematic and require a tailored intervention from a health care provider. 20
This study aimed to explore the association of women’s pre-existing attitudes toward
menopause, aging, and perception of stress with subsequent intensity of vasomotor
symptoms often associated with menopausal transition (hot flashes, night sweats, day
sweats, and vaginal dryness). The longitudinal nature of this investigation permitted
assessment of these pre-existing perceptions before periods of amenorrhea were noted and
prior to any increase in FSH. We hypothesized that psychological factors (perceived stress
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and attitudes toward aging and menopause) would predict intensity of vasomotor symptoms
after controlling for biological and social factors (age, income, education, ethnicity, FSH
level, body weight, and smoking).
METHODS
This analysis is drawn from a larger 5-year study of midlife women and bio-psycho-social
health. Demographic data were collected at enrollment and updated on an annual basis; data
on symptoms and menstrual cycles were collected every two months; and laboratory data
and questionnaire data were obtained every six months. Attrition at 18 months was less than
10% and was associated with subject burden or geographical relocation. Details of the
recruitment and retention strategies are reported elsewhere.21
Data from the larger study for this analysis included demographic characteristics from
baseline (Time 1), data on attitudes toward menopause and aging, and stress perception at
the 6 month interval (Time 2), and height and weight measures obtained at enrollment, 6
months, and 12 months (Time 3). Body mass index (BMI) was calculated at each visit by
weight in kilograms divided by height in meters squared. Urinary FSH level was obtained at
baseline, 6-months, and 12 months and used in conjunction with regularity of menstrual
cycles to categorize menopausal status. First morning voided samples were obtained, frozen,
and then processed and analyzed for FSH level by Endocrine Sciences, Inc. laboratory
facilities (Esoterix Endocrinology, Calabasas Hills, CA). Cycle length change that would
indicate ‘early’ transition to menopause (or premenopause in this study) and cycle
irregularity that would indicate ‘late’ transition (or perimenopause) was collected during
telephone calls at 2-month intervals when symptoms were also assessed.
All participants reported regular menstrual cycles and had low levels of FSH consistent with
functioning ovaries and premenopausal status at the initial assessment. Symptoms were
assessed for presence and intensity every two months by telephone during the first year of
the study, and symptom intensity at the 12-month (Time 3) assessment was the outcome
variable for this analysis. Predictor variables included biological (age, BMI, smoking, FSH
levels, and menopause status); social (education, income, and ethnicity); and psychological
(attitudes toward aging and menopause, and perceived stress).
Study Instruments
Attitude toward menopause was measured with the Attitudes Toward Menopause Checklist
created by Neugarten et al.22 The instrument consists of 35 items rated on a 4-point Likert
scale from strongly agree (1) to strongly disagree (4). Internal consistency reliability was
adequate (Cronbach alpha = .80) and concurrent validity between this tool and Bowles’
Menopause Attitude Scale was sufficient (Pearson r = .63).22
The Attitude Toward Aging scale was used to measure attitude toward aging.23 This scale
has 22 items rated on a 4-point Likert scale from strongly agree(1) to strongly disagree(4). It
combines items from other instruments that have demonstrated adequate content validity and
high reliability coefficients reported elsewhere in similar community based samples.23 A
higher score indicates a more positive attitude for both scales.23
Stress perception was measured using four items developed by the research team to address
specific sources of stress (work, family, personal, and health) and then an item about overall
level of current stress in their lives. Participants were asked to rate their overall stress on a 5-
point Likert scale from very stressful(1) to not at all stressful(5). Concurrent validity
(Pearson r = −.64) was obtained when compared with scores on the 10-item Perceived Stress
Scale that assesses general stress during the past month.24
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A composite sum of intensity of the four most common menopausal symptoms (hot flashes,
night sweats, day sweats, and vaginal dryness) was computed from an alphabetized list of 52
symptoms in the Women’s Health Study Symptom Questionnaire.25 These data were
collected by telephone interview every two months. The 12-month composite score was
used as the dependent variable. Vaginal dryness, although less common than the three
vasomotor symptoms, has been reported during menopause transition2 and was equal in
prevalence to day sweats in this sample. To assess intensity, participants were asked, “did
you experience [symptom] over the past week?” If experienced, they were then asked to rate
it “minimal (1)” if the feeling was very minor, “mild (2)” if it only slightly interfered with
their daily function, “moderate (3)” if it noticeably interfered with their daily function, and
“extreme (4)” if it was the worst they had ever felt. The total intensity score of the four
combined symptoms could range from 0 to 16.
Statistical Analyses
Pearson correlation analysis examined bivariate relationships between independent and
dependent continuous variables and Chi-square was used to examine dichotomous
outcomes. One-way ANOVA and multiple comparison analysis (Tukey’s post hoc) were
used to test differences in means between the three ethnic groups. Hierarchical linear
regression models were used in the final analysis to estimate the amount of variance
explained by the predictor variables after controlling for selected potential confounding
biological and social factors.
RESULTS
Sample Characteristics
The total number of participants at the initial assessment was 347 and their demographic
data are reported in more detail elsewhere.21 Since the aim of this analysis was to examine
how stress and attitudes influenced reporting of symptoms attributed to menopause, and
symptoms could alter one’s attitudes and perceived stress, 16 women who had high FSH
levels and reported changes in menstrual regularity indicative of ‘late transition’ at Time 2
were excluded from the current analyses. The study sample thus consisted of 266 women
who remained in the study for the first 12 months and completed the Time 3 assessment.
There were no significant differences in attitudes toward menopause or aging between those
who remained in this analysis at 12 months (Time 3) and those who did not remain in the
analysis.
Descriptive data for all variables are reported in Table 1. One-way analysis of variance
(ANOVA) and post hoc analyses demonstrated significant differences (P < .05) between
ethnic groups in: 1) income level, with European Americans having higher income than the
other two groups; 2) education level, with Latinas less educated than the other two groups);
and 3) BMI, with European Americans lower than the other two groups. There were no
group differences in FSH level, reproductive stage of menopause, or smoking history.
Attitude Toward Menopause and Attitude Toward Aging
The mean score for Attitude Toward Menopause was 73.5 (SD 8.5) with a range of 46 to
110. The mean score for Attitude Toward Aging was 58.9 (SD = 6.9) with a range of 38 to
74. These two instruments were significantly correlated (r = .396) but the correlation was
not strong enough to conclude that these were measuring the same concept. In other words,
the more positive the attitude toward menopause, the more positive the attitude toward
aging, but attitude about one was not the same or predictive of the other. A one-way
ANOVA revealed no differences in mean Attitude Toward Menopause scores between the
three ethnic groups. However, there was a significant ethnic group difference in Attitude
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Toward Aging scores, with European and African Americans scoring significantly higher (P
< .01), reflecting a more positive attitude toward aging than Mexican/Central Americans
(Table 1).
Stress Perception
At each time point, close to 75% of participants reported their specific family, personal,
work and health stress levels to be either “fairly stressful” or “very stressful.” The overall
current level of perceived stress at Time 2 ranged from 1(high) to 5 (low), with a median of
3.0 (fairly stressful) and mean of 2.8 (SD = .95). One-way ANOVA demonstrated no ethnic
group difference in overall level of perceived stress (Table 1).
Menopausal Status and Symptoms
At 12 months, 266 women continued to have low FSH levels and regular menstrual cycles.
Yet 35.7% (n = 95) reported at least one of the four most common symptoms of menopause:
8% (n = 21) reported day sweats; 8% (n = 22) reported hot flashes; 12% (n = 31) reported
night sweats; and 8% (n = 21) reported vaginal dryness. Of those who reported any of the
four symptoms, 23% (n = 22) were African American, 37% (n = 35) were European
American, and 40% (n = 38) were Mexican/Central American. These ethnic differences did
not reach statistical significance (p = .16).
Although there were no differences in menopausal status or age between the ethnic groups,
nearly twice as many Mexican/Central American women (6%; n = 16) reported having both
hot flashes and night sweats when compared to European American (3%; n = 8) and African
American (4%; n = 9) women (p < .01).
Intensity of Symptoms at 12 months (Time 3)
Of the 266 participants available for analysis at 12 months, 77% (n = 205) reported no
symptoms; 18% (n = 49) had mild symptoms (score 1 to 4); and 5% (n = 13) had moderate
symptom intensity (score 5 to 12). No one had severe (score 13 to16) symptom intensity in
this sample. European Americans reported significantly less intense symptom experience
than Mexican/Central Americans (P < .05) only after Tukey’s post hoc analysis was
conducted. Correlates of Symptom Intensity
Women with lower income, a more negative attitude toward aging, and higher perceived
stress (low score), reported more intense symptoms at Time 3 (Table 2). The women were
all between 40 and 50 years of age, and there was a non-significant (P = .051) trend toward
the older women reporting more intense symptoms than the younger women. A hierarchical
linear regression analysis included all 11 biological, social, and psychological variables in
the model to examine which set of predictors best account for the variance in symptom
intensity at 12 months More intense symptoms at 12 months were reported by the older
women who had less income, higher overall stress perception, a more negative attitude
toward aging, and a more positive attitude toward menopause. The final model accounted
for 14% of the variance in symptom intensity at 12 months.
DISCUSSION
Even though the overall prevalence of menopausal symptoms was low in this community-
based sample of healthy women most likely in early menopause transition, some did report
symptoms. Psychological factors (level of perceived stress and attitudes toward aging and
menopause) were significant predictors of self-reported menopause symptom intensity at 12
months. These factors remained significant when key biological factors that included BMI,
smoking, age, FSH level and menopause status and key social factors including income,
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education and ethnicity were included in the model. We anticipated that negative attitudes
would be associated with higher symptom intensity. This was the case in regards to attitude
toward aging; however, women with a more positive attitude toward menopause later
reported more intense symptoms. This contradicts Bloch’s findings in a cross-sectional
survey of 51 women between 43 and 63 years of age where those with a negative attitude
toward menopause were more distressed by their symptoms.8 In this study, attitudes were
assessed 6 month prior to symptom experience, and it is possible that as symptoms may
have increased, a change in attitude may have been seen.
Our finding related to attitude toward aging and impact on symptom experience supports
previous studies.8, 10 In this community-based sample of healthy midlife women, a negative
attitude toward aging was associated with later symptom intensity. This may reflect the
concerns women have about aging in general. Viewed through Lazarus’ theory of stress and
coping, 18 results would indicate that, as women appraise their symptom experience, they
may interpret their symptoms as a sign of aging and their symptom experience would be
intensified if they had a negative attitude toward aging.
Even though many women in this sample did not report intense symptoms in this early
transition period, those who did have intense symptoms also reported high levels of stress at
their previous assessment point six months earlier. This effect may be due to biological
interactions within the endocrine system itself, or may be a result of symptoms being an
added stressor in a woman’s life. If a woman had recently experienced a high level of stress,
the symptoms of menopause may be experienced as more intense. Their perception of stress
was linked to menopausal symptoms in a recent investigation but was likely due to the
cross-sectional nature of the study.11 We found no differences in the overall perception of
stress between the three ethnic groups, regardless of income and education, but most of our
sample appraised their lives as stressful or very stressful and this was associated with their
symptom experience.
The difference in prevalence of menopausal symptoms noted between ethnic groups
supports findings from other studies.13, 15, 26–28 Avis, et al.27 evaluated the effect of
menopausal changes on health-related quality of life and found that when compared to other
ethnic groups studied, Hispanic women had lower quality of life subscales. Avis et al.26 and
Gold et al. 28 documented that hot flashes were more often reported by African Americans
than other ethnic groups. Both African American and Hispanic women reported more
vasomotor symptoms when compared to Japanese, Chinese, or European American women
in Gold et al.’s study.28 In our sample, a larger percentage of Mexican/Central American
women reported vasomotor symptoms than did European Americans or African Americans.
However, symptoms had a relatively low prevalence and the difference in symptom intensity
between European American and Mexican/Central American women did not remain
significant after adjusting for income and education. All three ethnic groups had similar
attitudes toward menopause, but the significant difference in attitude toward aging between
European American and Mexican/Central American women needs further investigation in
relation to socio-cultural beliefs about aging.29 These data support results from a large
international study in Latin America that found an alarming decrease in quality of life
among midlife women when compared to younger women.30
The results of the present study support prior associations between income and symptom
experience.2, 14, 28 Gold, et al. reported that after adjusting for other risk factors, the
prevalence of symptoms was higher for those who had greater difficulty paying for basic
needs.28 Guthrie et al. found that women who reported bothersome hot flushes were less
likely to be in full or part-time paid work.14
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One limitation to this longitudinal study is that by the third assessment at 12 months,
participants were between 41 and 51 years of age and many had not yet entered late
transition stage and most had low symptom intensity. Thus, statistical power to detect
significant differences was limited. However there were 69 women who reported either hot
flashes or night sweats, and 31 women who reported both, while still being considered
‘premenopausal’ (or early transition) at Time 3 (as assessed by FSH level and menstrual
cycle regularity).
CLINICAL IMPLICATIONS
Clinicians caring for midlife women should be aware that women report symptoms even
before they are “officially” in late transition or ‘perimenopause,’ and while their FSH
levels remain normal, and their cycles remain regular. As has been suggested, 5 7 the
changes in cycle length that women experience before the onset of irregular cycles may
be accompanied by various symptoms. A clinical checklist of menstrual changes (cycle
length, menstrual flow and duration) and symptom intensity may enhance
communication for women who do not readily report their symptom experience.
The results of this study also support the need for women’s healthcare providers to be
alert to midlife women who may be experiencing high levels of stress or reporting
concerns about aging. These women may be at risk for distressing menopausal symptoms
as they transition through the stages of menopause. The association between income and
symptoms found in this study and other studies warrants the need to assess economic
struggles that midlife women may be experiencing and to be alert to their impact on
symptom experience. Additionally, clinicians who work with midlife populations of
Latinas should consider the potential for decreased quality of life related to aging and
transitioning through menopause. A bilingual checklist may improve communication of
concerns between Latinas and their healthcare provider.
What causes some women to experience menopausal symptoms more intensely than
others, and the extent to which some women report their experiences as more distressful
than others, remains largely unexplained. The finding that many women determined to be
‘premenopause’ in this study nonetheless experienced symptoms suggests the need for
further research on women in their early 40s, prior to changes in regularity of menstrual
cycles. These findings also support that women may begin experiencing changes earlier
than the onset of changes in periods of amenorrhea and FSH levels. Furthermore,
additional inquiry is needed to better understand the association between lower income
and symptom experience. The complexity of midlife women’s lives pose challenges to
researchers and healthcare providers alike. The many variables and factors that impact
symptom experience may be more thoroughly addressed through a qualitative approach
in order to better understand individual women’s experiences during the decade that
surrounds menopausal transition.
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Table 1
Characteristics of 266 Midlife Women by Ethnic Group
Participants at T3 who were pre-
menopausal at T2a
Total
N = 266
African
American
n=61
European
American
n=135
Mexican/Central
American
n=70
Age at T3, mean (SD),y 44.3 (2.32) 44.1 (2.24) 44.4 (2.16) 44.5 (2.38)
Income at T3, median $51,000 $41,000 $61,000c $46,000
Level of Education at T3, n (%)
 12th grade or less 17 (6.4) 3 (5) 4 (3) 14 (20)
 college or higher, n (%) 169 (64.5) 41 (67) 99 (73) 30 (43)c
Current smoker at T3, n (%) 26 (10) 9 (15) 12 (9) 5 (7)
Body mass index (BMI) at T3.,
mean (SD) 27.7 (6.4) 29.3 (6.7) 26.2 (6.0) c 29.2 (6.2)
Follicle-stimulating hormone (FSH),
mean (SD), IU/dL
.88 (1.4) 1.06 (1.6) .79 (1.4) .89 (1.2)
(Not sure how to handle the ± here
in the last three columns.)
Attitude Toward Menopause scale
score at T2, mean (SD) 73.5 (8.5) 75.4 (9.2) 72.9 (7.3) 72.9 (9.6)
Attitude Toward Aging scale score
at T2, mean (SD) 58.9 (6.9) 59.3 (7.4) 60.0 (6.1) 56.1 (7.1) c
Overall current stress at T2,
mean (SD)
2.8 (.95) 2.9 (1.0) 2.7(.93) 2.8 (.94)
Intensity of Symptomsd at T3, mean
(SD)
.89 (2.2) .89 (1.9) .64 (1.8) 1.4 (3.0)
Hot flashes or night sweats, n (%)
71 (27) 18 (30) 35 (26) 18 (26)
Both hot flashes and night sweats, n
(%)
33 (12) 9 (15) 8 (6) 16 (23)b
a
T2=Time 2=six month interval; T3=Time 3=12 month interval
b
P < .01 (One-way ANOVA )
c
P < .001 (One-way ANOVA )
d
composite variable that included intensity of four symptoms: hot flashes, night sweats, day sweats, and vaginal dryness
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Table 2
Bio-Psycho-Social Variables Independently Associated with Menopausal Symptom Intensity (N = 266).
Variable Pearson correlation
coefficient
Biological
  Age .11
  Follicle-stimulating
hormone (FSH)
.00
  Menopause status −.04
  Smoking .07
  Body mass index (BMI) .11
Social
  Education −.05
  Income
−.20a
Psychological
Attitude Toward
Menopause
.05
Attitude Toward Aging
−.18b
Perceived Stress
−.16c
The Pearson correlation coefficient refers to the strength of the correlation between the variables in Column 1 and Symptom Intensity. Small
correlations are indicated by a coefficient range of .1 to .3, moderate correlations from .4 to .6 and strong correlations .7 and above. Generally, a
negative coefficient indicates an inverse relationship. The level of perceived stress variable was coded such that a low score (1) = more stress than a
high score (5) Predictor variables were measured at T2 (at 6 months); Outcome and potential confounding variables were measured at T3 (at 12
months) in attempt to assess a temporal relation
aP < .05
b
P < .01
c
P < .001
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